Vault-13

Exome Asset Management LLC

NEW YORK, NY · CIK 2011932 · 13F filing filed 2025-08-15

SEC-registered investment adviser since 2021 · limited liability company

As an employer

$117.7m reported value +5.4% vs Q1 2025
52positions
41.2%in top 10
18 new 8 added 17 reduced 15 sold out vs Q1 2025

Options: 7 call positions ($9.3m notional), 4 put positions ($7.5m notional) – listed below, not included above.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ISHARES TR PUT PUT 200,000 $7.4m6.25% 6.25% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 200.0k
2 BRIDGEBIO PHARMA INC COM BBIO BBIO 155,533 $6.7m5.71% 5.71% ReducedShares held: Q3 2024 422.0k, Q4 2024 246.7k, Q1 2025 165.5k, Q2 2025 155.5k -10.0k -9,963 -6.0%
3 GUARDANT HEALTH INC COM GH GH 98,182 $5.1m4.34% 4.34% ReducedShares held: Q3 2024 179.6k, Q4 2024 147.8k, Q1 2025 127.2k, Q2 2025 98.2k -29.0k -29,000 -22.8%
4 GERON CORP COM GERN GERN 3,414,377 $4.8m4.09% 4.09% AddedShares held: Q3 2024 1.8m, Q4 2024 1.6m, Q1 2025 3.2m, Q2 2025 3.4m +198.9k +198,920 6.2%
5 IONIS PHARMACEUTICALS INC COM IONS IONS 121,116 $4.8m4.07% 4.07% ReducedShares held: Q3 2024 0, Q4 2024 61.4k, Q1 2025 135.6k, Q2 2025 121.1k -14.5k -14,500 -10.7%
6 TENET HEALTHCARE CORP COM NEW THC THC 27,000 $4.8m4.04% 4.04% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 27.0k
7 COGENT BIOSCIENCES INC COM COGT COGT 533,647 $3.8m3.26% 3.26% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 621.7k, Q2 2025 533.6k -88.0k -88,031 -14.2%
8 CYTOKINETICS INC COM NEW CYTK CYTK 115,817 $3.8m3.25% 3.25% AddedShares held: Q3 2024 117.2k, Q4 2024 65.9k, Q1 2025 103.5k, Q2 2025 115.8k +12.3k +12,334 11.9%
9 REPLIMUNE GROUP INC COM REPL REPL 397,846 $3.7m3.14% 3.14% AddedShares held: Q3 2024 0, Q4 2024 54.7k, Q1 2025 294.8k, Q2 2025 397.8k +103.0k +103,000 34.9%
10 ELI LILLY & CO COM LLY LLY 4,673 $3.6m3.10% 3.10% UnchangedShares held: Q3 2024 20.9k, Q4 2024 8.2k, Q1 2025 4.7k, Q2 2025 4.7k
11 SOLENO THERAPEUTICS INC COM SLNO SLNO 41,641 $3.5m2.96% 2.96% ReducedShares held: Q3 2024 0, Q4 2024 77.3k, Q1 2025 43.4k, Q2 2025 41.6k -1.8k -1,800 -4.1%
12 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 6,358 $3.5m2.94% 2.94% UnchangedShares held: Q3 2024 14.9k, Q4 2024 7.4k, Q1 2025 6.4k, Q2 2025 6.4k
13 DISC MEDICINE INC COM IRON IRON 61,356 $3.2m2.76% 2.76% ReducedShares held: Q3 2024 129.0k, Q4 2024 69.1k, Q1 2025 61.7k, Q2 2025 61.4k -300 -300 -0.5%
14 NATERA INC COM NTRA NTRA 18,650 $3.2m2.68% 2.68% UnchangedShares held: Q3 2024 44.9k, Q4 2024 22.4k, Q1 2025 18.6k, Q2 2025 18.6k
15 FULCRUM THERAPEUTICS INC COM FULC FULC 444,949 $3.1m2.60% 2.60% ReducedShares held: Q3 2024 0, Q4 2024 283.6k, Q1 2025 689.1k, Q2 2025 444.9k -244.2k -244,188 -35.4%
16 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 84,339 $3.0m2.54% 2.54% UnchangedShares held: Q3 2024 266.1k, Q4 2024 77.4k, Q1 2025 84.3k, Q2 2025 84.3k
17 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 308,298 $2.9m2.45% 2.45% ReducedShares held: Q3 2024 0, Q4 2024 318.9k, Q1 2025 337.2k, Q2 2025 308.3k -28.9k -28,900 -8.6%
18 VERASTEM INC COM NEW VSTM VSTM 599,900 $2.5m2.12% 2.12% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 599.9k
19 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 59,002 $2.5m2.11% 2.11% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 59.0k
20 PENUMBRA INC COM PEN PEN 9,000 $2.3m1.96% 1.96% UnchangedShares held: Q3 2024 0, Q4 2024 9.0k, Q1 2025 9.0k, Q2 2025 9.0k
21 89BIO INC COM ETNB ETNB 233,426 $2.3m1.95% 1.95% ReducedShares held: Q3 2024 601.2k, Q4 2024 225.3k, Q1 2025 353.9k, Q2 2025 233.4k -120.5k -120,456 -34.0%
22 TRAVERE THERAPEUTICS INC COM TVTX TVTX 153,278 $2.3m1.93% 1.93% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 118.0k, Q2 2025 153.3k +35.3k +35,261 29.9%
23 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 166,944 $2.2m1.86% 1.86% AddedShares held: Q3 2024 276.3k, Q4 2024 137.7k, Q1 2025 142.7k, Q2 2025 166.9k +24.2k +24,200 16.9%
24 WAYSTAR HLDG CORP COM WAY WAY 46,900 $1.9m1.63% 1.63% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 46.9k
25 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 277,317 $1.9m1.63% 1.63% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 289.7k, Q2 2025 277.3k -12.4k -12,373 -4.3%
26 10X GENOMICS INC CL A COM TXG TXG 163,658 $1.9m1.61% 1.61% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 163.7k
27 DYNE THERAPEUTICS INC COM DYN DYN 195,933 $1.9m1.59% 1.59% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 258.4k, Q2 2025 195.9k -62.5k -62,458 -24.2%
28 REGENXBIO INC COM RGNX RGNX 226,060 $1.9m1.58% 1.58% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 405.3k, Q2 2025 226.1k -179.2k -179,221 -44.2%
29 UNIVERSAL HLTH SVCS INC CL B UHS UHS 10,100 $1.8m1.55% 1.55% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 10.1k
30 VERA THERAPEUTICS INC CL A VERA VERA 76,700 $1.8m1.54% 1.54% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 76.7k
31 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 62,700 $1.8m1.53% 1.53% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 51.3k, Q2 2025 62.7k +11.4k +11,405 22.2%
32 APELLIS PHARMACEUTICALS INC COM APLS APLS 98,600 $1.7m1.45% 1.45% NewShares held: Q3 2024 200.7k, Q4 2024 119.5k, Q1 2025 0, Q2 2025 98.6k
33 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 124,470 $1.6m1.39% 1.39% AddedShares held: Q3 2024 119.8k, Q4 2024 81.5k, Q1 2025 71.4k, Q2 2025 124.5k +53.0k +53,032 74.2%
34 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 172,883 $1.5m1.32% 1.32% AddedShares held: Q3 2024 393.0k, Q4 2024 0, Q1 2025 60.6k, Q2 2025 172.9k +112.3k +112,283 185.3%
35 KARYOPHARM THERAPEUTICS INC NOTE 3.000%10/1 KPTI 3 10.15.25 KPTI 3 10.15.25 2,000,000 $1.5m1.30% 1.30% UnchangedShares held: Q3 2024 4.0m, Q4 2024 2.0m, Q1 2025 2.0m, Q2 2025 2.0m
36 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 73,000 $1.5m1.26% 1.26% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 73.0k
37 SAREPTA THERAPEUTICS INC NOTE 1.250% 9/1 SRPT 1.25 09.15.27 SRPT 1.25 09.15.27 2,000,000 $1.4m1.23% 1.23% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 2.0m
38 GOSSAMER BIO INC COM GOSS GOSS 1,097,999 $1.4m1.15% 1.15% UnchangedShares held: Q3 2024 937.0k, Q4 2024 1.1m, Q1 2025 1.1m, Q2 2025 1.1m
39 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 53,744 $1.1m0.95% 0.95% ReducedShares held: Q3 2024 240.3k, Q4 2024 152.0k, Q1 2025 102.9k, Q2 2025 53.7k -49.2k -49,200 -47.8%
40 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 29,100 $1.0m0.88% 0.88% NewShares held: Q3 2024 94.0k, Q4 2024 37.6k, Q1 2025 0, Q2 2025 29.1k
41 MBX BIOSCIENCES INC COM MBX MBX 63,076 $719.7k0.61% 0.61% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 133.1k, Q2 2025 63.1k -70.0k -70,037 -52.6%
42 ALVOTECH ORDINARY SHARES ALVO ALVO 78,372 $714.8k0.61% 0.61% ReducedShares held: Q3 2024 90.1k, Q4 2024 90.1k, Q1 2025 90.1k, Q2 2025 78.4k -11.7k -11,728 -13.0%
43 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 36,574 $662.4k0.56% 0.56% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 36.6k
44 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 213,544 $597.9k0.51% 0.51% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 213.5k
45 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 13,100 $559.5k0.48% 0.48% UnchangedShares held: Q3 2024 21.7k, Q4 2024 13.1k, Q1 2025 13.1k, Q2 2025 13.1k
46 VYNE THERAPEUTICS INC COM COM 208,970 $344.8k0.29% 0.29% ReducedShares held: Q3 2024 706.9k, Q4 2024 353.4k, Q1 2025 462.8k, Q2 2025 209.0k -253.8k -253,831 -54.9%
47 INSTIL BIO INC COM NEW TIL TIL 16,200 $337.4k0.29% 0.29% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 16.2k
48 ANAPTYSBIO INC COM ANAB ANAB 15,000 $333.0k0.28% 0.28% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 116.6k, Q2 2025 15.0k -101.6k -101,623 -87.1%
49 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 114,145 $309.3k0.26% 0.26% UnchangedShares held: Q3 2024 0, Q4 2024 256.4k, Q1 2025 114.1k, Q2 2025 114.1k
50 LIQUIDIA CORPORATION COM NEW LQDA LQDA 20,500 $255.4k0.22% 0.22% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 20.5k
51 ARBUTUS BIOPHARMA CORP COM ABUS ABUS 75,484 $233.2k0.20% 0.20% NewShares held: Q3 2024 0, Q4 2024 28.3k, Q1 2025 0, Q2 2025 75.5k
52 ELEVATION ONCOLOGY INC COM COM 110,353 $40.5k0.03% 0.03% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 110.4k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
ASTRAZENECA PLC 32,534 $4.7m32.5k shares
AKERO THERAPEUTICS INC AKRO AKRO 76,379 $3.1m76.4k shares
VIRIDIAN THERAPEUTICS INC VRDN VRDN 217,294 $2.9m217.3k shares
SAVARA INC SVRA SVRA 836,397 $2.3m836.4k shares
GE HEALTHCARE TECHNOLOGIES I GEHC GEHC 25,400 $2.1m25.4k shares
IMMUNOME INC IMNM IMNM 263,841 $1.8m263.8k shares
BEIGENE LTD ONC ONC 6,500 $1.8m6.5k shares
DR REDDYS LABS LTD RDY RDY 117,500 $1.5m117.5k shares
NEKTAR THERAPEUTICS 2,232,453 $1.5m2.2m shares
ARVINAS INC ARVN ARVN 195,295 $1.4m195.3k shares
TREVI THERAPEUTICS INC TRVI TRVI 163,738 $1.0m163.7k shares
BIOHAVEN LTD BHVN BHVN 39,900 $959.2k39.9k shares
AKEBIA THERAPEUTICS INC AKBA AKBA 189,087 $363.0k189.1k shares
NUVATION BIO INC NUVB NUVB 96,311 $169.5k96.3k shares
APREA THERAPEUTICS INC APRE APRE 28,972 $59.1k29.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ASTRAZENECA PLC Put Put 28,362 $3.9m28.4k shares New
AKERO THERAPEUTICS INC AKRO · Put AKROPut 58,579 $3.1m58.6k shares New
ACADIA PHARMACEUTICALS INC ACAD · Call ACADCall 93,222 $2.0m93.2k shares New
NEKTAR THERAPEUTICS NKTR · Call NKTRCall 75,000 $1.9m75.0k shares New
CENCORA INC COR · Call CORCall 6,000 $1.8m6.0k shares New
TRAVERE THERAPEUTICS INC TVTX · Call TVTXCall 110,000 $1.6m110.0k shares Unchanged
ULTRAGENYX PHARMACEUTICAL IN RARE · Call RARECall 37,500 $1.4m37.5k shares New
UNITEDHEALTH GROUP INC UNH · Call UNHCall 1,400 $436.8k1.4k shares New
ALTIMMUNE INC ALT · Put ALTPut 107,000 $414.1k107.0k shares New
FULCRUM THERAPEUTICS INC FULC · Call FULCCall 20,000 $137.6k20.0k shares New
MEREO BIOPHARMA GROUP PLC MREO · Put MREOPut 14,600 $39.6k14.6k shares New